Shandong Kunda announces the public disclosure of its expansion project for over 20,000 tons of chloropyridine products.
To expand its upstream and downstream industrial chain, optimize its product structure, and enhance its risk resistance and market profitability, Kunda Biotechnology invested 54.5981 million RMB in the construction of a chloropyridine workshop expansion and renovation project (Phase III) within the factory premises of Shandong Kunda Biotechnology Company Ltd. in the Yishui County Economic Development Zone. Building upon the Phase II project, this expansion involves increasing the number of reactors or reaction vessels in the 2-chloropyridine, 2,6-dichloropyridine, and trichloropyridine/tetrachloropyridine/pentachloropyridine production units. This will add new production capacity of 1475 t/a of 2-chloropyridine, 9306 t/a of 2,6-dichloropyridine, 6875 t/a of trichloropyridine, 1280 t/a of tetrachloropyridine, 2815 t/a of pentachloropyridine, 11985 t/a of 31% hydrochloric acid, and 7046 t/a of 10.5% sodium hypochlorite.
